Condition

Mouth Cancer

ClinicalTrials.gov condition label

Clinical trials3

Recruiting1

Common interventions4

Lead sponsors shown3

Clinical trials

3 shown

DESTINY-PANTUMOUR04NCT07124000 · 2025-09-18

RECRUITING

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneNCT03602079 · 2018-07-16

COMPLETED

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid TumorsNCT00028405 · 2001-11-01

COMPLETED

Common interventions

A166DRUG1LS 11(Taporfin Sodium)DRUG1Lumaflex Light Delivery CatheterDEVICE1Trastuzumab deruxtecanDRUG1

Leading sponsors

AstraZeneca1Klus Pharma Inc.1Light Sciences LLC1

Trial status mix

COMPLETED2

RECRUITING1

Phase mix

PHASE12

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.